Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinamide Riboside (NR) in Paclitaxel-induced Peripheral Neuropathy

NCT03642990 is registered in ClinicalTrials.gov with Donna Hammond, PhD as lead sponsor.

NCT NCT03642990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinamide Riboside (NR) in Paclitaxel-induced Peripheral Neuropathy
Lead sponsor
Donna Hammond, PhD
Phase
Phase 2
Overall status
Terminated
Start date
November 8, 2019
Completion date
February 24, 2022
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic, chemotherapy-induced peripheral neuropathy, endometrial cancer stage iv, head and neck cancer stage iv, platinum-resistant recurrent ovarian cancer